API 0.74% $1.35 australian pharmaceutical industries limited

api - thoughts, page-4

  1. 6,376 Posts.
    lightbulb Created with Sketch. 2614
    I like API because the metrics are all improving. The current price is about 4 times last years cashflow, and a bit over 5 times the cashflow of the year before.

    We already know that NPAT is up and sales are up, if cashflow is up as well, then this is in the bargain class category.

    Even with the thin margins API are doing well and retiring debt.
    Everyone of the spikes down in the last couple of years has proven to be a buy point. It was down at the lows this time only briefly.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.